Загрузка...
A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium
PURPOSE: Clinical benign prostatic hyperplasia (BPH) is primarily diagnosed based on a diverse array of progressive lower urinary tract symptoms (LUTS) and is likely distinct from histological BPH, which is detected by the presence of non-malignant proliferation of prostate cells but may or may not...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105378/ https://ncbi.nlm.nih.gov/pubmed/18280515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2007.11.049 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|